Heart rhythm · 2026
The Cardiac Calcium Handling Machinery is Remodeled in Friedreich's Ataxia.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Abou-Assali Obada, Czornobil Roman, Daniel Darryl, Sara Karthik, Thummala Harsha, Smith Teagen, Remily-Wood Elizabeth, Lynch David R, McDonald Thomas V, Noujaim Sami F, Chidipi Bojjibabu
Аннотация
BACKGROUND: Friedreich's ataxia (FA) is a progressive neurodegenerative disorder caused by an expansion of the GAA triplet repeat in the Frataxin (FXN) gene, leading to reduced frataxin expression. FA commonly affects the heart, causing hypertrophy, heart failure, and fibrosis. The mechanisms of FA-associated cardiac dysfunction may involve disrupted calcium handling and mitochondrial impairment.
OBJECTIVE: To investigate whether abnormalities in calcium handling machinery contributes to cardiac dysfunction in FA.
METHODS: Human left ventricular tissue from FA patients and unaffected donors, and an FXN knock-out (FXN-KO) mouse model, were analyzed. In mice, cardiac function was assessed by echocardiography and ECG. Calcium-handling protein expression was evaluated with Western blotting, RT-qPCR, and immunofluorescence. Single-cell contractility and calcium transients were measured in isolated ventricular myocytes. Mitochondrial function was assessed via confocal imaging to quantify mitochondrial membrane potential (Δψm) and reactive oxygen species (ROS).
RESULTS: FXN-KO mice exhibited significant reductions in ejection fraction, stroke volume, fractional shortening, and cardiac output, with increased LV mass and elevated end-diastolic and end-systolic volumes. Strain analysis revealed increased global and peak longitudinal strain. On ECG, the RR, PR, QRS, and QTc intervals were prolonged. Both human FA and FXN-KO hearts showed downregulation of SERCA2a and Ryr2, with reduced phospholamban phosphorylation. FXN-KO mice also showed upregulation of mitochondrial calcium-handling proteins, including MCU and VDAC, depolarized Δψm, and elevated ROS.
CONCLUSION: Cardiac dysfunction in FA is associated with impaired calcium handling, mitochondrial dysregulation, and systolic impairment, identifying potential molecular targets for therapy.
OBJECTIVE: To investigate whether abnormalities in calcium handling machinery contributes to cardiac dysfunction in FA.
METHODS: Human left ventricular tissue from FA patients and unaffected donors, and an FXN knock-out (FXN-KO) mouse model, were analyzed. In mice, cardiac function was assessed by echocardiography and ECG. Calcium-handling protein expression was evaluated with Western blotting, RT-qPCR, and immunofluorescence. Single-cell contractility and calcium transients were measured in isolated ventricular myocytes. Mitochondrial function was assessed via confocal imaging to quantify mitochondrial membrane potential (Δψm) and reactive oxygen species (ROS).
RESULTS: FXN-KO mice exhibited significant reductions in ejection fraction, stroke volume, fractional shortening, and cardiac output, with increased LV mass and elevated end-diastolic and end-systolic volumes. Strain analysis revealed increased global and peak longitudinal strain. On ECG, the RR, PR, QRS, and QTc intervals were prolonged. Both human FA and FXN-KO hearts showed downregulation of SERCA2a and Ryr2, with reduced phospholamban phosphorylation. FXN-KO mice also showed upregulation of mitochondrial calcium-handling proteins, including MCU and VDAC, depolarized Δψm, and elevated ROS.
CONCLUSION: Cardiac dysfunction in FA is associated with impaired calcium handling, mitochondrial dysregulation, and systolic impairment, identifying potential molecular targets for therapy.